Clexane 10,000 IU (100mg)/1ml Solution for Injection in pre-filled syringes Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

clexane 10,000 iu (100mg)/1ml solution for injection in pre-filled syringes

sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 100 milligram(s)/millilitre - heparin group; enoxaparin

Eloxatin 5 mg/ml Concentrate for Solution for Infusion Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

eloxatin 5 mg/ml concentrate for solution for infusion

sanofi-aventis ireland limited t/a sanofi - oxaliplatin - concentrate for solution for infusion - 5 milligram(s)/millilitre - platinum compounds; oxaliplatin

Tarivid 200mg Film-Coated Tablets Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

tarivid 200mg film-coated tablets

sanofi-aventis ireland limited t/a sanofi - ofloxacin - film-coated tablet - 200 milligram(s) - fluoroquinolones; ofloxacin

Tavanic 5 mg/ml solution for infusion Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

tavanic 5 mg/ml solution for infusion

sanofi-aventis ireland limited t/a sanofi - levofloxacin - solution for infusion - 5 milligram(s)/millilitre - fluoroquinolones; levofloxacin

Clexane 2,000 IU (20mg) /0.2 mL Solution for Injection in pre-filled syringes Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

clexane 2,000 iu (20mg) /0.2 ml solution for injection in pre-filled syringes

sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 20 mg/ 0.2 millilitre(s) - heparin group; enoxaparin

Clexane 4,000 IU (40mg) /0.4 mL Solution for Injection in pre-filled syringes Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

clexane 4,000 iu (40mg) /0.4 ml solution for injection in pre-filled syringes

sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 40 milligram(s) - heparin group; enoxaparin

Clexane 6,000 IU (60mg) /0.6 mL Solution for Injection in pre-filled syringes Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

clexane 6,000 iu (60mg) /0.6 ml solution for injection in pre-filled syringes

sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 60 mg/ 0.6 millilitre(s) - heparin group; enoxaparin

Clexane 8,000 IU (80mg) /0.8 mL Solution for Injection in pre-filled syringes Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

clexane 8,000 iu (80mg) /0.8 ml solution for injection in pre-filled syringes

sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 80 milligram(s) - heparin group; enoxaparin

Clexane Forte 12,000 IU (120mg) / 0.8 mL Solution for Injection in pre-filled syringes Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

clexane forte 12,000 iu (120mg) / 0.8 ml solution for injection in pre-filled syringes

sanofi-aventis ireland limited t/a sanofi - enoxaparin sodium - solution for injection in pre-filled syringe - 120 milligram(s) - heparin group; enoxaparin

Lemtrada New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

lemtrada

sanofi-aventis new zealand limited - alemtuzumab 10 mg/ml - concentrate for infusion - 10 mg/ml - active: alemtuzumab 10 mg/ml excipient: dibasic sodium phosphate disodium edetate dihydrate monobasic potassium phosphate polysorbate 80 potassium chloride sodium chloride - treatment of relapsing forms of multiple sclerosis (ms) for patients with active disease defined by clinical or imaging features to slow the accumulation of physical disability and reduce the frequency of clinical relapses.